Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Familial Cancer|April 30, 2024
Impact of hormonal contraception on endometrial histology in patients with Lynch syndrome, a retrospective pilot studyMarie Mawet, Clémence Evrevin, Antoine Dardenne, et al.Bulletin Du Cancer|August 13, 2022
[Hereditary gastric cancer syndromes and their association with specific histological subtypes]Antoine Dardenne, Laura Sirmai, Julie Metras, et al.Bulletin Du Cancer|March 12, 2026
[Pancreatic acinar cell carcinoma: Clinical and theranostic characteristics]Andrea Marques, Léo Mas, Antoine Dardenne, et al.International Journal of Cancer|January 31, 2020
Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combinationEleonore De Guillebon, Antoine Dardenne, Antonin Saldmann, et al.Familial Cancer|January 31, 2025
Thirty-year compliance with a surveillance program for patients with familial adenomatous polyposisBoris Cleret de Langavant, Jéremie H Lefèvre, Julie Metras, et al.European Journal of Human Genetics : EJHG|March 18, 2025
Pathogenic germline variants in patients with early-onset colorectal cancer according to phenotypeAntoine Dardenne, Marion Dhooge, Noémie Basset, et al.International Journal of Cancer|December 29, 2025
Organ-sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision-makingMartin Duval, Antoine Dardenne, Thomas Samaille, et al.Journal of Medical Genetics|November 20, 2025
Expert endoscopic surveillance in <i>CDH1</i> pathogenic variant carriers seems safe, even after positive (pT1a) biopsiesPatrick R Benusiglio, Romain Leenhardt, Caroline Duros, et al.The Oncologist|April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint InhibitorsRaphael Colle, Sara Lonardi, Marine Cachanado, et al.European Journal of Human Genetics : EJHG|May 13, 2026
Follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: Data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.Pageof 2